Jazz Pharmaceuticals
JAZZ | NASDAQ
$215.98
+$8.15 (+3.92%)
At close: Oct 30, 2026, 4:00 PM ET
$217.50
+$1.52 (+0.70%)
Pre-market:
Nov 2, 2026, 7:12 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 4.27B | 4.07B | 3.83B | 3.66B | 3.09B | 2.36B |
Cost of Revenue | 503.3M | 445.71M | 435.58M | 540.52M | 440.76M | 148.92M |
Gross Profit | 3.76B | 3.62B | 3.4B | 3.12B | 2.65B | 2.21B |
Operating Income | 224.42M | 716.63M | 578.58M | -65.53M | 170.28M | 378.07M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -628.59M | 468.69M | 294.92M | -382.71M | -113.55M | 272.13M |
Net Income | -356.15M | 560.12M | 414.83M | -224.06M | -328.95M | 238.62M |
Selling & General & Admin | 1.81B | 1.39B | 1.34B | 1.42B | 1.45B | 854.23M |
Research & Development | 782.74M | 884M | 849.66M | 590.45M | 505.75M | 335.38M |
Other Expenses | 947.86M | 637.31M | 627.28M | 1.18B | 525.77M | 646.97M |
Operating Expenses | 3.54B | 2.91B | 2.82B | 3.18B | 2.48B | 1.84B |
Interest Expense | 195.05M | 238.1M | 289.44M | 288.24M | 278.77M | 99.71M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.04B | 3.35B | 3.26B | 3.72B | 2.92B | 1.99B |
Income Tax Expense | -272.44M | -91.43M | -119.91M | -158.65M | 216.12M | 33.52M |
Shares Outstanding (Basic) | 60.98M | 61.84M | 63.29M | 62.54M | 59.69M | 55.71M |
Shares Outstanding (Diluted) | 60.98M | 66.01M | 72.07M | 62.54M | 59.69M | 56.52M |
EPS (Basic) | -5.84 | 9.06 | 6.55 | -3.58 | -5.51 | 4.28 |
EPS (Diluted) | -5.84 | 8.65 | 6.10 | -3.58 | -5.51 | 4.22 |
EBITDA | 108.46M | 1.52B | 1.45B | 1.47B | 1.03B | 1.04B |
EBIT | -433.54M | 861.64M | 810.73M | 839.14M | 475.26M | 765.46M |
Depreciation & Amortization | 542M | 660.07M | 638.7M | 629.47M | 552.48M | 278.25M |
Add to Watchlist
Select watchlists to add or remove JAZZ